Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To determine the efficacy and safety of ONO-1078 in patients with chronic sinusitis in a double-blind, randomized, placebo-controlled, parallel group, multi-center study
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| P | Placebo Comparator |
| |
| E | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Placebo | Drug | 0 mg BID for 12 weeks |
| |
| Pranlukast hydrate |
| Measure | Description | Time Frame |
|---|---|---|
| nasal congestion | 12 weeks | |
| rhinorrhea | 12 weeks | |
| postnasal drip | 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| easiness of blowing nose | 12 weeks | |
| easiness of removing postnasal drip | 12 weeks | |
| dull headache |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Hajime Yamamotoya | Ono Pharmaceutical Co., Ltd. | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chubu region | Chūbu | Japan | ||||
| Hokuriku region |
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
225 mg BID for 12 weeks |
|
| 12 weeks |
| Hokuriku |
| Japan |
| Kanto region | Kanto | Japan |
| Kinki region | Kinki | Japan |
| Kyushu region | Kyushu | Japan |
| Tohoku region | Tōhoku | Japan |